BOSNALIJEK / ABOUT US
Leading Pharmaceutical Company in Bosnia and Herzegovina
We are dedicated to the development of preventive action, palliation and cures and to improving the quality of life.
READ MORE
QUALITY, SAFETY AND EFFICACY
Continuously committed to the needs of our customers
We are committed to the continuous and consistent application of quality standards in all aspects of our business operations and processes.
READ MORE
CAREER / EDUCATION AND DEVELOPMENT
Our employees make our business successful
We devote special attention to talent management, career development and succession planning for key organisational positions.
READ MORE
BOSNALIJEK / SOS CHILDREN’S VILLAGES
We invest in our children’s healthy and carefree living
The second generation of children is being raised in an SOS children’s village family supported by Bosnalijek.
READ MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Investors
We are committed to meeting the expectations of our customers, shareholders and employees
MORE
Products
We are continuously committed to our customers and pay special attention to monitoring and analysing their needs
MORE
Career
Join our family and make your contribution to improving the health of people around the world
MORE
PRESS CENTRE / CORPORATE MOVIE
New corporate movie – Health comes first!
Bosnalijek is known as a manufacturer of highest-quality medications. The company’s quality assurance system is fully in line with national and international rules and standards of good manufacturing practice, meeting the expectations and justifying the trust of our customers, partners, and regulatory institutions. Modernizing our facilities, always advancing our knowledge, and improving our working conditions are the key to our growth. By creating new jobs, investing in knowledge, talent, and young people, and supporting the local community, we are asserting our role as a leader in positive social processes both in the country and abroad. Our vision is to boldly step into new areas and technologies and directly set trends in the pharmaceutical industry, always bearing in mind the highest value — health comes first. Health comes first!
NOTICE
NOTICE ON THE CONVENING OF THE NEXT EXTRAORDINARY GENERAL MEETING OF BOSNALIJEK D.D.
In accordance with provisions of Article 233, paragraph (2) and (3) of the applicable Companies Act and Article 55, paragraph (2) and (3) of the applicable Statute of Bosnalijek d.d., pursuant to Decision No: 118/23 of 20 January 2023, the Supervisory Board of the Company issues the following:
In detail
ANNUAL REGULAR ASSEMBLY
ANNOUNCEMENT ON THE CONVENING OF THE EXTRAORDINARY ASSEMBLY OF BOSNALIJEK JSC
In accordance with the provisions of Article 230, paragraph (1) of the current Law on Business Companies and Article 48, paragraph (1) of the current Statute of Bosnalijek j.s.c., based on Decision no. 6454/22 dated on 12/22/2022, the Supervisory Board of the Company announces:
In detail
PRESS CENTRE/NEWS
Bosnalijek breaks its own business records
The largest domestic pharmaceutical company, Bosnalijek j.s.c., in the first nine months of 2022, achieved total revenue of 120.5 million BAM and thereby achieved revenue growth of 33.4 million BAM or 38 percent compared to the same period last year.
In detail
februar 09. 2023 |
SASE |
BSNLR - Bosnalijek d.d. Sarajevo: 12,47 3,89%